Eric C. Seales, Ph.D. - Publications
Affiliations: | 2004 | University of Alabama, Birmingham, Birmingham, AL, United States |
Area:
Pathology, Cell Biology, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2008 | Shaikh FM, Seales EC, Clem WC, Hennessy KM, Zhuo Y, Bellis SL. Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms. Experimental Cell Research. 314: 2941-50. PMID 18703050 DOI: 10.1016/J.Yexcr.2008.07.021 | 0.605 | |||
2006 | Seales EC, Micoli KJ, McDonald JM. Calmodulin is a critical regulator of osteoclastic differentiation, function, and survival. Journal of Cellular Biochemistry. 97: 45-55. PMID 16216008 DOI: 10.1002/Jcb.20659 | 0.343 | |||
2005 | Seales EC, Shaikh FM, Woodard-Grice AV, Aggarwal P, McBrayer AC, Hennessy KM, Bellis SL. A protein kinase C/Ras/ERK signaling pathway activates myeloid fibronectin receptors by altering beta1 integrin sialylation. The Journal of Biological Chemistry. 280: 37610-5. PMID 16157583 DOI: 10.1074/Jbc.M508476200 | 0.43 | |||
2005 | Seales EC, Jurado GA, Brunson BA, Wakefield JK, Frost AR, Bellis SL. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Research. 65: 4645-52. PMID 15930282 DOI: 10.1158/0008-5472.Can-04-3117 | 0.771 | |||
2003 | Seales EC, Jurado GA, Singhal A, Bellis SL. Ras oncogene directs expression of a differentially sialylated, functionally altered beta1 integrin. Oncogene. 22: 7137-45. PMID 14562042 DOI: 10.1038/Sj.Onc.1206834 | 0.818 | |||
2002 | Semel AC, Seales EC, Singhal A, Eklund EA, Colley KJ, Bellis SL. Hyposialylation of integrins stimulates the activity of myeloid fibronectin receptors. The Journal of Biological Chemistry. 277: 32830-6. PMID 12091385 DOI: 10.1074/Jbc.M202493200 | 0.798 | |||
Show low-probability matches. |